Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 55 for “"Modifying treatment"”.

  1. Statistical Methods for Analysis of Structural Magnetic Resonance Imaging in Patients with Multiple Sclerosis

    … on structural MRI in patients with MS to disease-modifying treatment and other clinical information. Chapter 2 of the thesis is an introduction to sMRI data. Chapter 3 and 4 of the thesis deal with MS lesion segmentation using multi-sequence structural MRI. Chapter 5 is a culmination of this work. …

    jhu Repository record for Statistical Methods for Analysis of Structural Magnetic Resonance Imaging in Patients with Multiple Sclerosis (opens in a new tab)

  2. EARLY POSTNATAL DEVELOPMENTAL ABNORMALITIES IN PERIPHERAL NERVE MYELINATION IN A CMT1A MOUSE MODEL

    … neuropathy. At present, no effective disease-modifying treatment exists for CMT1A, and clinical care is limited to supportive management of symptoms. Therefore, it is crucial to define the onset of myelin pathology and understand whether CMT1A primarily arises from abnormal myelin development …

    jhu Repository record for EARLY POSTNATAL DEVELOPMENTAL ABNORMALITIES IN PERIPHERAL NERVE MYELINATION IN A CMT1A MOUSE MODEL (opens in a new tab) Embargoed until 2028-05-01

  3. Ex vivo investigation of mechanisms to prevent oxidatively induced alterations in axonal mitochondria in murine nervous system models

    … effects of teriflunomide, an approved disease-modifying treatment for MS, on oxidatively caused mitochondrial alterations. In the third study we explored the effects of teriflunomide on oxidative stress-induced mitochondrial alterations in acute hippocampal slices, which represent an ex vivo …

    fu-berlin Repository record for Ex vivo investigation of mechanisms to prevent oxidatively induced alterations in axonal mitochondria in murine nervous system models (opens in a new tab)

  4. Pain and neurodiversity in refractory rheumatoid arthritis

    … by painful joint swelling. Despite disease-modifying treatments, chronic pain remains a highly prevalent concern for patients, imposing significant physical and psychological burden and reducing quality of life. Persistent pain, especially when disproportionate to inflammation, suggests the …

    kings Repository record for Pain and neurodiversity in refractory rheumatoid arthritis (opens in a new tab) Download PDF for Pain and neurodiversity in refractory rheumatoid arthritis (opens in a new tab)

  5. Individuali išsėtinės sklerozės recidyvuojančios remituojančios ligos eigos gydymo prognozė. Klinikinis atvejis /

    … the most appropriate personalized disease modifying treatment (DMT) strategy that aligns with an individual patient‘s needs, it is essential to predict the likely course of disease progression and the extent of disability the patient may develop over time. To date, none of the novel …

    vilnius Repository record for Individuali išsėtinės sklerozės recidyvuojančios remituojančios ligos eigos gydymo prognozė. Klinikinis atvejis / (opens in a new tab)

  6. Vitaminas D ir išsėtinė sklerozė. Klinikiniai atvejai /

    … correlation between first-line disease-modifying therapy with high dose vitamin D and disease activity or disability shown in clinical trials. So, vitamin D significance for patients with multiple sclerosis is still unclear. This study describes three female patients with …

    vilnius Repository record for Vitaminas D ir išsėtinė sklerozė. Klinikiniai atvejai / (opens in a new tab)

  7. Neuroinflammation and amyloid-β in early Alzheimer’s disease. Insight into the earliest events using mouse models

    … but there currently exists no effective treatment that can stop nor slow the progression of the disease. The current dogma in the field postulates that the appearance of extracellular amyloid-beta (Aβ) plaques, a histopathological hallmark of the disease, is the trigger for downstream, …

    lund Repository record for Neuroinflammation and amyloid-β in early Alzheimer’s disease. Insight into the earliest events using mouse models (opens in a new tab) Download PDF for Neuroinflammation and amyloid-β in early Alzheimer’s disease. Insight into the earliest events using mouse models (opens in a new tab)

  8. Identification and characterisation of HLA-DRB1*0101 restricted CD4+ T cell epitopes in the major grass pollen allergens Phl p 1 and Phl p 5

    … using whole extract is an effective disease-modifying treatment, but it is associated with severe, life-threatening systemic IgE-mediated side-effects. One strategy to improve safety and clinical efficacy is to develop peptide immunotherapy for grass pollen allergy.<br/>The aim of this thesis …

    kings Repository record for Identification and characterisation of HLA-DRB1*0101 restricted CD4+ T cell epitopes in the major grass pollen allergens Phl p 1 and Phl p 5 (opens in a new tab)

  9. Metabotropic Glutamate Receptor Signalling and Phenotype Progression in Huntington's Disease Mice

    … its cause decades ago, there is still no disease modifying treatment available for HD patients. Current evidence indicates that exacerbated glutamate signalling in the striatum plays a key role in the pathophysiology of HD. Within the striatum, metabotropic glutamate receptor (mGluR) 2/3 are …

    ottawa-retro Repository record for Metabotropic Glutamate Receptor Signalling and Phenotype Progression in Huntington's Disease Mice (opens in a new tab)

  10. Kognityvinių ir demografinių rodiklių reikšmė prognozuojant Alzheimerio ligos atsaką į gydymą /

    … to apply symptomatic or in the future, disease-modifying treatment and slow down cognitive decline, prolong the period of independent living, propose psychosocial measures, and reduce the cost of care for the sick. In clinical practice, the diagnosis of AD is based on cognitive impairment, which …

    vilnius Repository record for Kognityvinių ir demografinių rodiklių reikšmė prognozuojant Alzheimerio ligos atsaką į gydymą / (opens in a new tab)

  11. The significance of cognitive and demographic indicators in predicting the response of Alzheimer’s disease to treatment /

    … to apply symptomatic or in the future, disease-modifying treatment and slow down cognitive decline, prolong the period of independent living, propose psychosocial measures, and reduce the cost of care for the sick. In clinical practice, the diagnosis of AD is based on cognitive impairment, which …

    vilnius Repository record for The significance of cognitive and demographic indicators in predicting the response of Alzheimer’s disease to treatment / (opens in a new tab)

  12. Studies on the Influence of Infecting Dose on the Severity of Disease

    … undergo spontaneous recovery and not to get modifying treatment The implications of these findings for the pathogenesis of malaria and for natural malaria are discussed. The final section explores more general issues of the relationship between dose and pathogenesis.

    lshtm Repository record for Studies on the Influence of Infecting Dose on the Severity of Disease (opens in a new tab) Download PDF for Studies on the Influence of Infecting Dose on the Severity of Disease (opens in a new tab)

  13. The Contribution of Spleen Tyrosine Kinase to the Pathobiology of Alzheimer’s Disease

    … As of 2018, there exists no disease modifying treatment for AD and the cause of sporadic AD remains elusive. We investigated the contribution of the spleen tyrosine kinase (SYK) in AD pathobiology. Syk is wellknown for its involvement in B-cell receptor (BCR) signaling but our …

    the-open-u Download PDF for The Contribution of Spleen Tyrosine Kinase to the Pathobiology of Alzheimer’s Disease (opens in a new tab)

  14. Faith, hope and fallacy: an idiographic exploration of the experiences of people with Multiple Sclerosis participating in research trials

    … MS has no cure although available disease modifying treatment (DMT) options have increased significantly over recent years. In order for these treatments to have gained authorisation for use, many clinical trials have been undertaken involving people with MS (pwMS). However, little is …

    salford Download PDF for Faith, hope and fallacy: an idiographic exploration of the experiences of people with Multiple Sclerosis participating in research trials (opens in a new tab)

  15. BIOPHYSICAL REGULATION OF SYNOVIAL FIBROBLASTS AND MACROPHAGES IN OSTEOARTHRITIS

    … of chronic pain and disability, yet no disease-modifying treatment exists. Long regarded as a condition of mechanical wear-and-tear driven by cartilage breakdown, OA is now understood to be a whole-joint disease in which chronic inflammation and progressive tissue remodeling of the synovial …

    penn Repository record for BIOPHYSICAL REGULATION OF SYNOVIAL FIBROBLASTS AND MACROPHAGES IN OSTEOARTHRITIS (opens in a new tab)

  16. Ara h 1 Peptide Immunotherapy in a Mouse Model of Peanut-Induced Anaphylaxis

    … is a marked absence of widespread, practical treatments available for peanut-allergic patients. Peptide immunotherapy, a disease-modifying treatment that uses short peptides recognized by T cells, has been shown to reduce allergic symptoms of allergic rhinoconjunctivitis. This project …

    mcmaster Repository record for Ara h 1 Peptide Immunotherapy in a Mouse Model of Peanut-Induced Anaphylaxis (opens in a new tab)

  17. Identifying the Cellular Mechanisms of Alzheimer's Disease (AD) and Impact of Miniscopes in Vivo

    … are currently no clinically meaningful disease-modifying treatment options available to patients and the condition is ultimately fatal. While the pathological and functional changes associated with AD are well-characterised within the central nervous system (CNS), the aetiological link between …

    auckland-ms Repository record for Identifying the Cellular Mechanisms of Alzheimer's Disease (AD) and Impact of Miniscopes in Vivo (opens in a new tab)

  18. Cognitive Rehabilitation and Telehealth Videoconferencing: Developing an Accessible Intervention for Subjective Cognitive Impairment, Mild Cognitive Impairment, and Dementia

    … Teleheath videoconferencing is one way to make treatment more accessible. Over the course of three studies, this dissertation developed goal-oriented cognitive rehabilitation as an intervention for individuals with subjective cognitive impairment (SCI), mild cognitive impairment (MCI), and …

    sask Repository record for Cognitive Rehabilitation and Telehealth Videoconferencing: Developing an Accessible Intervention for Subjective Cognitive Impairment, Mild Cognitive Impairment, and Dementia (opens in a new tab)

Page 1 of 3